Clinical Trial Update: Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing aldoxorubicin to topotecan in metastatic small cell lung cancer; results assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Aldoxorubicin (aldoxorubicin)
• Topotecan (topotecan)

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Metastatic Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-06-25